- Home
- BSY vs MRNA Comparison
BSY vs MRNA Comparison
Compare BSY & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSY
- MRNA
- Stock Information
- Founded
- BSY 1984
- MRNA 2010
- Country
- BSY United States
- MRNA United States
- Employees
- BSY N/A
- MRNA N/A
- Industry
- BSY Retail: Computer Software & Peripheral Equipment
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSY Technology
- MRNA Health Care
- Exchange
- BSY Nasdaq
- MRNA Nasdaq
- Market Cap
- BSY 14.6B
- MRNA 16.5B
- IPO Year
- BSY 2020
- MRNA 2018
- Fundamental
- Price
- BSY $47.49
- MRNA $40.30
- Analyst Decision
- BSY Buy
- MRNA Hold
- Analyst Count
- BSY 8
- MRNA 19
- Target Price
- BSY $58.43
- MRNA $79.50
- AVG Volume (30 Days)
- BSY 972.9K
- MRNA 7.9M
- Earning Date
- BSY 11-07-2024
- MRNA 02-20-2025
- Dividend Yield
- BSY 0.50%
- MRNA N/A
- EPS Growth
- BSY 105.33
- MRNA N/A
- EPS
- BSY 1.11
- MRNA N/A
- Revenue
- BSY $1,313,914,000.00
- MRNA $5,081,000,000.00
- Revenue This Year
- BSY $11.36
- MRNA N/A
- Revenue Next Year
- BSY $10.75
- MRNA N/A
- P/E Ratio
- BSY $43.17
- MRNA N/A
- Revenue Growth
- BSY 9.06
- MRNA N/A
- 52 Week Low
- BSY $43.82
- MRNA $35.80
- 52 Week High
- BSY $57.19
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- BSY 47.40
- MRNA 40.83
- Support Level
- BSY $47.18
- MRNA $38.52
- Resistance Level
- BSY $48.25
- MRNA $40.36
- Average True Range (ATR)
- BSY 1.09
- MRNA 2.45
- MACD
- BSY -0.02
- MRNA 0.13
- Stochastic Oscillator
- BSY 30.97
- MRNA 22.76
About BSY Bentley Systems Incorporated Class B
Bentley Systems is a software vendor that caters to engineers, architects, constructors, and geospatial professionals by enabling design, modeling, simulation and project, and data management of infrastructure assets. The firm delivers solutions via the cloud, desktop, and hybrid environments. While Bentley is relatively small in comparison with peers like Autodesk, it shines in core specialty areas, like bridge or rail design, as opposed to being more broad-based in its applications. As of fiscal 2022, approximately 58% of revenue is derived from outside the U.S. (with 28% of revenue coming from EMEA and 18% coming from APAC as of fiscal 2022). Bentley's largest end market is the public works and utilities sector, which represents approximately two thirds of revenue.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.